{"id":2187,"date":"2023-10-02T14:24:10","date_gmt":"2023-10-02T13:24:10","guid":{"rendered":"https:\/\/pprd.theramex.com\/pt\/?p=2187"},"modified":"2023-10-02T14:24:10","modified_gmt":"2023-10-02T13:24:10","slug":"theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc","status":"publish","type":"post","link":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\/","title":{"rendered":"Theramex Announces Agreement to Acquire the European Rights to Duphaston\u00ae and Femoston\u00ae From Viatris, Inc."},"content":{"rendered":"\n<p><strong>London, 02 October 2023<\/strong> &#8211; Theramex, a leading global speciality pharmaceutical company dedicated to women\u2019s health, is pleased to announce that it has entered into an agreement to acquire the European rights to Duphaston\u00ae and Femoston\u00ae from Viatris Inc.&nbsp; Viatris retains the rights for Australia and Japan. The transaction is subject to customary regulatory and anti-trust approvals.&nbsp;<\/p>\n\n\n\n<p>\u201cAs we continue to strengthen our commitment to women\u2019s health and improve our patients access to high quality treatments,we are excited to acquire new products to expand our Menopause portfolio.\u201d &#8211; <strong>Rob Stewart, CEO of Theramex.<\/strong><\/p>\n\n\n\n<p>Duphaston\u00ae (dydrogesterone) and Femoston\u00ae (estradiol\/dydrogesterone) may be prescribed in indications related to hormone replacement therapy (HRT).<\/p>\n\n\n\n<p><strong>About Theramex<\/strong><\/p>\n\n\n\n<p>Theramex is a leading, global specialty pharmaceutical company dedicated to women and their health. With a broad portfolio of innovative and established brands covering contraception, fertility, menopause and osteoporosis, Theramex supports women at different stages of their lives. Our vision is to be a lifetime partner for women and the healthcare professionals who treat them by providing innovative, effective solutions that care for and support women as they advance through each stage of their lives. To learn more about Theramex, please visit <a href=\"\/Users\/KatjjL\/AppData\/Local\/Microsoft\/Windows\/INetCache\/Content.Outlook\/UAT81E8V\/www.theramex.com\">www.theramex.com.<\/a><\/p>\n\n\n\n<p><strong>For further information about Theramex, please contact:<\/strong><\/p>\n\n\n\n<p>Katja Lundell, Senior Director, Global Head of Policy, Pricing and Communications.<br>Email:&nbsp;<a href=\"mailto:Katja.Lundell@theramex.com\"><strong>Katja.Lundell@theramex.com<\/strong><\/a><br>Phone&nbsp;: +44 203 962 5555<br><a href=\"http:\/\/www.theramex.com\/\"><strong>www.theramex.com<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>London, 02 October 2023 &#8211; Theramex, a leading global speciality pharmaceutical company dedicated to women\u2019s health, is pleased to announce that it has entered into an agreement to acquire the European rights to Duphaston\u00ae and Femoston\u00ae from Viatris Inc.&nbsp; Viatris retains the rights for Australia and Japan. The transaction is subject to customary regulatory and [&hellip;]<\/p>\n","protected":false},"author":31,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2187","post","type-post","status-publish","format-standard","hentry","category-uncategorised"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Theramex Announces Agreement to Acquire the European Rights to Duphaston\u00ae and Femoston\u00ae From Viatris, Inc. - Theramex Portugal<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Theramex Announces Agreement to Acquire the European Rights to Duphaston\u00ae and Femoston\u00ae From Viatris, Inc. - Theramex Portugal\" \/>\n<meta property=\"og:description\" content=\"London, 02 October 2023 &#8211; Theramex, a leading global speciality pharmaceutical company dedicated to women\u2019s health, is pleased to announce that it has entered into an agreement to acquire the European rights to Duphaston\u00ae and Femoston\u00ae from Viatris Inc.&nbsp; Viatris retains the rights for Australia and Japan. The transaction is subject to customary regulatory and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"Theramex Portugal\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-02T13:24:10+00:00\" \/>\n<meta name=\"author\" content=\"garethwesley\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"garethwesley\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\\\/\"},\"author\":{\"name\":\"garethwesley\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#\\\/schema\\\/person\\\/4a1ee296d18078c874f0f4cf868281f3\"},\"headline\":\"Theramex Announces Agreement to Acquire the European Rights to Duphaston\u00ae and Femoston\u00ae From Viatris, Inc.\",\"datePublished\":\"2023-10-02T13:24:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\\\/\"},\"wordCount\":244,\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\\\/\",\"url\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\\\/\",\"name\":\"Theramex Announces Agreement to Acquire the European Rights to Duphaston\u00ae and Femoston\u00ae From Viatris, Inc. - Theramex Portugal\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#website\"},\"datePublished\":\"2023-10-02T13:24:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#\\\/schema\\\/person\\\/4a1ee296d18078c874f0f4cf868281f3\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Theramex Announces Agreement to Acquire the European Rights to Duphaston\u00ae and Femoston\u00ae From Viatris, Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#website\",\"url\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/\",\"name\":\"Theramex Portugal\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#\\\/schema\\\/person\\\/4a1ee296d18078c874f0f4cf868281f3\",\"name\":\"garethwesley\",\"url\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/author\\\/garethwesley\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Theramex Announces Agreement to Acquire the European Rights to Duphaston\u00ae and Femoston\u00ae From Viatris, Inc. - Theramex Portugal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\/","og_locale":"en_GB","og_type":"article","og_title":"Theramex Announces Agreement to Acquire the European Rights to Duphaston\u00ae and Femoston\u00ae From Viatris, Inc. - Theramex Portugal","og_description":"London, 02 October 2023 &#8211; Theramex, a leading global speciality pharmaceutical company dedicated to women\u2019s health, is pleased to announce that it has entered into an agreement to acquire the European rights to Duphaston\u00ae and Femoston\u00ae from Viatris Inc.&nbsp; Viatris retains the rights for Australia and Japan. The transaction is subject to customary regulatory and [&hellip;]","og_url":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\/","og_site_name":"Theramex Portugal","article_published_time":"2023-10-02T13:24:10+00:00","author":"garethwesley","twitter_card":"summary_large_image","twitter_misc":{"Written by":"garethwesley","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\/#article","isPartOf":{"@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\/"},"author":{"name":"garethwesley","@id":"https:\/\/www.theramex.com\/pt\/#\/schema\/person\/4a1ee296d18078c874f0f4cf868281f3"},"headline":"Theramex Announces Agreement to Acquire the European Rights to Duphaston\u00ae and Femoston\u00ae From Viatris, Inc.","datePublished":"2023-10-02T13:24:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\/"},"wordCount":244,"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\/","url":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\/","name":"Theramex Announces Agreement to Acquire the European Rights to Duphaston\u00ae and Femoston\u00ae From Viatris, Inc. - Theramex Portugal","isPartOf":{"@id":"https:\/\/www.theramex.com\/pt\/#website"},"datePublished":"2023-10-02T13:24:10+00:00","author":{"@id":"https:\/\/www.theramex.com\/pt\/#\/schema\/person\/4a1ee296d18078c874f0f4cf868281f3"},"breadcrumb":{"@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-announces-agreement-to-acquire-the-european-rights-to-duphaston-and-femoston-from-viatris-inc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.theramex.com\/pt\/"},{"@type":"ListItem","position":2,"name":"Theramex Announces Agreement to Acquire the European Rights to Duphaston\u00ae and Femoston\u00ae From Viatris, Inc."}]},{"@type":"WebSite","@id":"https:\/\/www.theramex.com\/pt\/#website","url":"https:\/\/www.theramex.com\/pt\/","name":"Theramex Portugal","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.theramex.com\/pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.theramex.com\/pt\/#\/schema\/person\/4a1ee296d18078c874f0f4cf868281f3","name":"garethwesley","url":"https:\/\/www.theramex.com\/pt\/novidades\/author\/garethwesley\/"}]}},"_links":{"self":[{"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/posts\/2187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/comments?post=2187"}],"version-history":[{"count":0,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/posts\/2187\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/media?parent=2187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/categories?post=2187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/tags?post=2187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}